急诊高风险分层联合高敏肌钙蛋白安全有效
该研究为阶梯楔形整群随机试验的二次分析,纳入31492例疑似急性冠脉综合征患者,评估高敏肌钙蛋白风险分层(低风险<5 ng/L,中风险5 ng/L至99百分位)的效果与安全性。结果显示实施后低、中风险患者住院时间均缩短,急诊出院率提高,且出院患者1年心梗或心源性死亡风险更低。
要点
- 低风险(<5 ng/L)和中风险(5 ng/L至99百分位)患者住院时间分别缩短2.2小时和4.8小时。
- 实施后低风险患者急诊出院率从62%升至83%,中风险从36%升至55%。
- 出院患者1年心梗或心源性死亡风险降低(aHR 0.65),低、中风险亚组均一致。
核心结论
- 高敏肌钙蛋白风险分层可缩短低、中风险疑似ACS患者住院时间并提高急诊出院率。
- 急诊出院患者后续1年心梗或心源性死亡风险更低,低、中风险亚组均如此。
研究设计与样本
- 阶梯楔形整群随机对照试验的二次分析,纳入31492例连续就诊的疑似急性冠脉综合征患者。
- 患者就诊时按高敏肌钙蛋白分为低风险(<5 ng/L)和中风险(5 ng/L至99百分位)。
主要发现
- 低风险患者住院时间由6.9±3.2小时降至4.7±2.8小时,差异2.2小时(95%CI 0.7-3.7),P<0.001。
- 中风险患者住院时间由15.8±4.7小时降至11.0±4.9小时,差异4.8小时(95%CI 3.8-5.8),P<0.001。
- 低风险患者急诊出院率由62%(4962/7941)升至83%(7747/9358),调整OR 3.31(95%CI 3.06-3.57)。
- 中风险患者急诊出院率由36%(2445/6759)升至55%(4095/7434),调整OR 2.06(95%CI 1.92-2.21)。
- 出院患者1年心梗或心源性死亡风险降低(1.5%[112/7407] vs 1.0%[124/11842],aHR 0.65,95%CI 0.50-0.86)。
临床怎么用
- 对疑似急性冠脉综合征患者,可用高敏肌钙蛋白进行低、中风险分层以辅助急诊决策。
- 低风险(<5 ng/L)和中风险(5 ng/L至99百分位)患者均可考虑缩短留观并提高急诊出院。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Implementation of an early rule-out pathway for myocardial infarction using high-sensitivity cardiac troponin to risk stratify patients reduces length of stay and hospital admission. Whether gains are similar in low- and intermediate-risk patients and those discharged were correctly identified as being at lower risk of future cardiovascular events is uncertain. OBJECTIVES: This study sought to evaluate the effectiveness and safety of risk stratification with high-sensitivity cardiac troponin in patients with suspected acute coronary syndrome stratified as low and intermediate risk. METHODS: In this secondary analysis of a stepped-wedge cluster-randomized controlled trial, we evaluated the effectiveness and safety of risk stratification with high-sensitivity cardiac troponin in 31,492 consecutive patients who presented with suspected acute coronary syndrome and identified as low (<5 ng/L) or intermediate (5 ng/L to 99th percentile) risk at presentation. The primary effectiveness outcome was length of hospital stay. The primary safety outcome was subsequent myocardial infarction or cardiac death at 1 year. RESULTS: Of 31,492 patients (59 ± 17 years, 45% women), 17,299 (54.9%) and 14,193 (45.1%) were low and intermediate risk, respectively. Following implementation, length of stay was reduced in low-risk (6.9 ± 3.2 vs 4.7 ± 2.8 hours: difference 2.2; 95% CI: 0.7-3.7 hours) and intermediate-risk (15.8 ± 4.7 vs 11.0 ± 4.9 hours: difference 4.8; 95% CI: 3.8-5.8 hours) patients (P < 0.001 for both). Discharge from the emergency department increased in low-risk (62% [4,962 of 7,941] vs 83% [7,747 of 9,358]; adjusted OR: 3.31; 95% CI: 3.06-3.57) and intermediate-risk (36% [2,445 of 6,759] vs 55% [4,095 of 7,434]; adjusted OR: 2.06; 95% CI: 1.92-2.21) patients. Following implementation, patients discharged were at lower risk of myocardial infarction or cardiac death at 1 year (1.5% [112 of 7,407] vs 1.0% [124 of 11,842]; adjusted HR [aHR]: 0.65; 95% CI: 0.50-0.86), whether stratified as low (0.6% vs 0.3%; aHR: 0.46; 95% CI: 0.26-0.83) or intermediate (3.4% vs 2.4%; aHR: 0.74; 95% CI: 0.55-0.99) risk at presentation. CONCLUSIONS: Risk stratification with high-sensitivity cardiac troponin reduced length of stay and increased discharge from the emergency department in both low- and intermediate-risk patients with suspected acute coronary syndrome. Patients discharged from the emergency department were at lower risk of subsequent myocardial infarction or cardiac death at 1 year. (High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction [HiSTORIC]; NCT03005158).
引用
- Li, Doudesis, Bularga, et al. Safety of Using Risk Stratification Along With High-Sensitivity Cardiac Troponin in the Emergency Department: A Secondary Analysis. J Am Coll Cardiol. 2025. PMID: 41193094. doi:10.1016/j.jacc.2025.08.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。